WebBiolytx Pharmaceuticals is an example of what life science companies go through. Biolytx has developed a novel new drug to fight antibiotic-resistant bacteria. ... Scott Meacham is president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state’s technology-based startup companies. i2E receives state appropriations from ... WebDec 15, 2015 · In 2005, Pereira founded the company Biolytx Pharmaceutical Corp., and she currently serves as Chief Scientific Officer for the company. In the last 10 years, antibiotic-resistant infections have ...
Biolytx Pharmaceuticals picks up $1.1 mill - i2E
WebWilliam A. Hagstrom. Mr. Hagstrom has served as a member of our Board of Directors since incorporation in 2005. He has served as the founder and CEO of Octave Bioscience, an early-stage diagnostics company focused on neurodegenerative diseases since 2014. WebBiolytx Pharmaceuticals is a pharmaceutical technology company developed by Dr. Anne Pereira and the University of Oklahoma Health Sciences Center. Still in the pre-clinical trial stage, the company's core technology is the development of a novel antibiotic peptide for use in treatment of serious hospital-acquired infections, including those ... fixtures and more
Management Team – Biolytx Pharmaceuticals Corp.
WebBiolytx Pharmaceuticals. Biolytx is an emerging drug development company confronting the crisis in antibiotic (AB) drug resistance through the advancement of a suite of … Dr. Pereira is the holder of 15 US patents and 4 foreign patents licensed to Biolytx. … The CSO of Biolytx characterized, sequenced, and cloned the peptide and … BP001. BP001 is an antibiotic and wound healing agent for infected eye wounds. … Pre-Clinical Stage. All of our drug candidates are in the pre-clinical stage … INVESTORS We completed a $1.5 million seed round of financing in 2015, led by … Biolytx Pharmaceuticals Targets Drug-Resistant Bacteria March 25 , 2015 – … Biolytx Pharmaceuticals Corporation 800 Research Parkway, Suite Oklahoma … William A Hagstrom Board Member and Co-Founder. Mr. Hagstrom has served as a … WebJul 29, 2024 · Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis – Drugs In Development, 2024, provides an overview of the Cystic Fibrosis (Respiratory) pipeline landscape. Cystic fibrosis (CF) is an inherited disease that causes mucus to build up and clog some of the body’s organs, particularly the lungs … WebBiolytx has a portfolio of antimicrobial peptides based on the naturally occurring human CAP37 (Cationic Antimicrobial Peptide), which is one of the proteins secreted at wound … fixtures and power supply